Injection as well as non-injection drug abuse among women sexual intercourse workers within Iran: An
Author : Cassidy Hagen | Published On : 14 Feb 2025
A mild and practical Pd/Xiang-Phos-catalyzed enantioselective intermolecular carboheterofunctionalization reaction of 2,3-dihydrofurans is developed, leading to various optically active fused furoindolines and tetrahydrofurobenzofurans. The key to this transformation is employing two newly modified N-Me-Xiang-Phos ligands ((S, RS)- N-Me-X4/X5) as chiral ligands under mild conditions. Moreover, this synthetic methodology can be efficiently applied to a variety of complex polysubstituted heterocycles with high chemo-, regio-, and enantio-selectivities via introducing diverse substituents on furan rings, which were hard to access by other routes.Most cancer chemotherapy regimens rely on the use of two or more chemotherapeutic agents. However, achieving the best possible dosing of the individual drugs can be challenging due to differences in metabolism, uptake, and clearance among other factors. L-Glutamic acid monosodium mw Here we describe a supramolecular strategy for achieving drug delivery in which the loading ratio of two active components is easily defined. Specifically, we report the formation of aggregates comprised of self-assembled amphiphiles between carboxylatopillar[6]arene (CP6A) and an oxaliplatin (OX)-type Pt(iv) prodrug (PtC10). The association constant (Ka) for the underlying host-guest interaction at pH 7.4 ((1.16 ± 0.03) × 104 M-1) is an order of magnitude higher than at pH 5.0 ((1.73 ± 0.15) × 103 M-1). A second chemotherapeutic, doxorubicin (DOX), may be encapsulated in the resulting vesicles (PtC10⊂CP6A) to give a supramolecular combination chemotherapeutic system DOX@PtC10⊂CP6A. Drug release studies served to confirm that PtC10 and DOX are released in acidic environments. Support for a synergistic antiproliferative effect relative to PtC10 + DOX came from cellular studies of DOX@PtC10⊂CP6A using the human liver hepatocellular carcinoma (HepG-2) cell line. In vivo studies revealed that DOX@PtC10⊂CP6A is not only able to retard tumor growth efficiently but also reduce drug-related toxic side effects in BALB/c nude mice bearing HepG-2 subcutaneous tumor xenografts. These favorable findings are attributed to the formation of a ternary complex that benefits from an enhanced permeability and retention (EPR) effect in vivo while allowing for the pH-based release of PtC10 and DOX at the tumor site.Time-resolved electron paramagnetic resonance (TREPR) spectroscopy has been used to study the proton coupled electron transfer (PCET) reaction between a ruthenium complex (Ru(bpz)(bpy)2) and several substituted hydroquinones (HQ). After excitation at 355 nm, the HQ moiety forms a strong hydrogen bond to the exposed N atoms in the bpz heterocycle. At some point afterwards, a PCET reaction takes place in which an electron from the O atom of the hydrogen bond transfers to the metal center, and the proton forming the hydrogen bond remains on the bpz ligand N atom. The result is a semiquinone radical (HQ˙), whose TREPR spectrum is strongly polarized by the triplet mechanism (TM) of chemically induced dynamic electron spin polarization (CIDEP). Closer examination of the CIDEP pattern reveals, in some cases, a small amount of radical pair mechanism (RPM) polarization. We hypothesize that when the HQ moiety has electron donating groups (EDGs) substituted on the ring, S-T- RPM polarization is observed in HQ˙. These anomalous intensities are accounted for by spectral simulation using polarization from S-T- mixing. The generation of S-T- RPM is attributed to slow radical separation after PCET due to stabilization of the positive charge on the ring by EDGs. Results from a temperature dependence support the hypothesis.While dual photocatalysis-transition metal catalysis strategies are extensively reported, the majority of systems feature two separate catalysts, limiting the potential for synergistic interactions between the catalytic centres. In this work we synthesised a series of tethered dual catalysts allowing us to investigate this underexplored area of dual catalysis. In particular, Ir(i) or Ir(iii) complexes were tethered to a BODIPY photocatalyst through different tethering modes. Extensive characterisation, including transient absorption spectroscopy, cyclic voltammetry and X-ray absorption spectroscopy, suggest that there are synergistic interactions between the catalysts. The tethered dual catalysts were more effective at promoting photocatalytic oxidation and Ir-catalysed dihydroalkoxylation, relative to the un-tethered species, highlighting that increases in both photocatalysis and Ir catalysis can be achieved. The potential of these catalysts was further demonstrated through novel sequential reactivity, and through switchable reactivity that is controlled by external stimuli (heat or light).Despite the successful debut of gold nanoclusters (Au NCs) in solar cell applications, Au NCs, compared to dyes and quantum dots, have several drawbacks, such as lower extinction coefficients. Any modulation of the physical properties of NCs can have a significant influence on the delicate control of absorbance, energy levels, and charge separation, which are essential to ensure high power conversion efficiency. To this end, we systematically alter the optoelectronic structure of Au18(SR)14 by Ag doping and explain its influence on solar cell performance. Our in-depth spectroscopic and electrochemical characterization combined with computational study reveals that the performance-dictating factors respond in different manners to the Ag doping level, and we determine that the best compromise is the incorporation of a single Ag atom into an Au NC. This new insight highlights the unique aspect of NCs-susceptibility to atomic level doping-and helps establish a new design principle for efficient NC-based solar cells.The misfolding and aberrant aggregation of proteins into fibrillar structures is a key factor in some of the most prevalent human diseases, including diabetes and dementia. Low molecular weight oligomers are thought to be a central factor in the pathology of these diseases, as well as critical intermediates in the fibril formation process, and as such have received much recent attention. Moreover, on-pathway oligomeric intermediates are potential targets for therapeutic strategies aimed at interrupting the fibril formation process. However, a consistent framework for distinguishing on-pathway from off-pathway oligomers has hitherto been lacking and, in particular, no consensus definition of on- and off-pathway oligomers is available. In this paper, we argue that a non-binary definition of oligomers' contribution to fibril-forming pathways may be more informative and we suggest a quantitative framework, in which each oligomeric species is assigned a value between 0 and 1 describing its relative contribution to the formation of fibrils.